Literature DB >> 31325172

Pharmacokinetics and tissue residues of enrofloxacin in the largemouth bass (Micropterus salmoides) after oral administration.

Qi Shan1, Jingxin Wang1,2, Guangming Zheng1, Xinping Zhu3, Yuanhao Yang4, Lisha Ma1, Cheng Zhao1, Lichun Li1, Yi Yin1.   

Abstract

The study was carried out to evaluate the pharmacokinetic disposition of enrofloxacin (ENF) with a single dose of 20 mg/kg after oral administration in largemouth bass (Micropterus salmoides) at 28°C. The concentrations of ENF and of its metabolite ciprofloxacin (CIP) in plasma, liver, and muscle plus skin in natural proportions were determined using HPLC. The concentration-time data for ENF in plasma were best described by a two-compartment open model. After oral administration, the maximum ENF concentration (Cmax ) of 10.99 μg/ml was obtained at 0.60 hr. The absorption half-life (T1/2Ka ) of ENF was calculated to be 0.07 hr whereas the elimination half-life (T1/2β ) of the drug was 90.79 hr. The estimates of area under the plasma concentration-time curve (AUC) and apparent volume of distribution (Vd/F) were 1,185.73 μg hr/ml and 2.21 L/kg, respectively. ENF residues were slowly depleted from the liver and muscle plus skin of largemouth bass with the T1/2β of 124.73 and 115.14 hr, respectively. Very low levels of ciprofloxacin were detected in the plasma and tissues. A withdrawal time of 24 days was necessary to ensure that the residues of ENF + CIP in muscle plus skin were less than the maximal residue limit (MRL) of 100 μg/kg established by the European Union.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  ciprofloxacin; enrofloxacin; largemouth bass; pharmacokinetics; tissue residues; withdrawal time

Mesh:

Substances:

Year:  2019        PMID: 31325172     DOI: 10.1111/jvp.12794

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  3 in total

1.  Pharmacokinetics and Tissue Distribution of Enrofloxacin Following Single Oral Administration in Yellow River Carp (Cyprinus carpio haematoperus).

Authors:  Fan Yang; Chao-Shuo Zhang; Ming-Hui Duan; Han Wang; Zhe-Wen Song; Hao-Tian Shao; Kai-Li Ma; Fang Yang
Journal:  Front Vet Sci       Date:  2022-02-04

Review 2.  Enrofloxacin-The Ruthless Killer of Eukaryotic Cells or the Last Hope in the Fight against Bacterial Infections?

Authors:  Łukasz Grabowski; Lidia Gaffke; Karolina Pierzynowska; Zuzanna Cyske; Marta Choszcz; Grzegorz Węgrzyn; Alicja Węgrzyn
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

3.  Pharmacokinetics and Tissue Residue Profiles of Enrofloxacin in Crucian Carp (Carassius auratus gibelio) Following Single and Multiple Oral Administration.

Authors:  Qi Shan; Heqing Huang; Guangming Zheng; Yi Yin; Xinping Zhu; Lisha Ma; Hao Zhou; Wenping Xie; Lichun Li; Shugui Liu; Jingxin Wang
Journal:  Front Vet Sci       Date:  2022-04-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.